Shopping Cart

No products in the cart.

AAMI CR513 2024

$80.17

AAMI CR513:2024 Guidance on radiation validation and routine maintenance for single-use systems used for pharmaceutical and biopharmaceutical manufacturing

Published By Publication Date Number of Pages
AAMI 2024
Guaranteed Safe Checkout
Category:

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

This consensus report provides guidance on simplified approaches for validation and routine control of single-use systems used for pharmaceutical and biopharmaceutical manufacturing sterilized by radiation.

PDF Catalog

PDF Pages PDF Title
1 AAMI CR513:2024; Guidance on radiation sterilization validation and routine control of single-use systems used for pharmaceutical and biopharmaceutical manufacturing
3 Title page
4 AAMI Consensus Report
5 Copyright information
Contents
6 Task Group representation
9 1 Purpose
1.1 Scope
2 References and resources
10 3 Terms and definitions
4 Definition and maintenance of product families for dose establishment and dose auditing
4.1 Representative product
4.1.1 Master product
11 4.1.2 Equivalent product
4.1.3 Simulated product
5 Selection and testing of product for establishing the sterilization dose
5.1 Selection of product to be tested
5.2 Sample item portion (SIP)
12 6 Sterile claim
7 Transfer of dose between radiation types
8 Application of dose
8.1 Application of verification dose to SUSs
8.2 Application of sterilization dose to SUSs
13 9 Risk assessment
9.1 Risk assessment for SAL
9.2 Risk assessment for simplification of SUSs for testing
10 Guidance on release and independent verification for the user
10.1 SUS release information
14 10.2 SUS user information
11 Regulatory aspects
AAMI CR513 2024
$80.17